Statement Of Cash Flows [Abstract]

GENFLOW BIOSCIENCES PLC - Filing #1906463

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-18 to 2021-12-31	2021-01-18 to 2021-12-31	2021-01-18 to 2021-12-31	2021-01-18 to 2021-12-31	2021-01-18 to 2021-12-31	2021-01-18 to 2021-12-31	As at 2021-01-18
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)	—	- GBP	1,335,321 GBP	- GBP	1,335,325 GBP	- GBP	1,335,325 GBP	—	- GBP	988,195 GBP	- GBP	988,195 GBP	- GBP	988,195 GBP	—
Adjustments to reconcile profit (loss) [abstract]
Adjustments for depreciation and amortisation expense	—	—	—	—	129 GBP	—	—	—	—	—	—	—	—	—	—
Adjustments for share-based payments	—	—	—	—	72,000 GBP	—	—	—	—	18,960 GBP	—	—	—	—	—
Cash flows from (used in) operating activities	—	—	—	—	1,368,324 GBP	—	—	—	—	747,377 GBP	—	—	—	—	—
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities	—	—	—	—	2,480 GBP	—	—	—	—	- GBP	—	—	—	—	—
Cash flows from (used in) investing activities	—	—	—	—	2,480 GBP	—	—	—	—	198,502 GBP	—	—	—	—	—
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities	—	—	—	—	3,499,516 GBP	—	—	—	—	783,711 GBP	—	—	—	—	—
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	—	—	—	—	2,128,183 GBP	—	—	—	—	224,004 GBP	—	—	—	—	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	—	—	—	—	4,038 GBP	—	—	—	—	- GBP	—	—	—	—	—
Cash and cash equivalents	2,356,225 GBP	—	—	—	—	—	—	224,004 GBP	—	—	—	—	—	—	- GBP